State Street’s CVS Health CVS Stock Holding History

State Street’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.26B	Sell	59,322,181 -861,562	-1%	-$66.4M	0.15%	122
2025 Q4	$4.78B	Buy	60,183,743 +1,245,457	+2%	+$98.2M	0.16%	110
2025 Q3	$4.44B	Buy	58,938,286 +149,701	+0.3%	+$10.3M	0.15%	112
2025 Q2	$4.06B	Buy	58,788,585 +800,414	+1%	+$52.5M	0.15%	125
2025 Q1	$3.93B	Buy	57,988,171 +1,035,212	+2%	+$61.9M	0.16%	119
2024 Q4	$2.56B	Buy	56,952,959 +425,050	+0.8%	+$23.8M	0.1%	176
2024 Q3	$3.55B	Buy	56,527,909 +1,989,066	+4%	+$116M	0.14%	132
2024 Q2	$3.22B	Sell	54,538,843 -465,432	-0.8%	-$29.1M	0.14%	132
2024 Q1	$4.39B	Sell	55,004,275 -198,849	-0.4%	-$15.2M	0.2%	98
2023 Q4	$4.36B	Buy	55,203,124 +1,104,000	+2%	+$78.6M	0.21%	90
2023 Q3	$3.78B	Sell	54,099,124 -1,778,263	-3%	-$126M	0.21%	96
2023 Q2	$3.86B	Buy	55,877,387 +855,269	+2%	+$60.9M	0.2%	97
2023 Q1	$4.09B	Sell	55,022,118 -2,857,185	-5%	-$240M	0.23%	87
2022 Q4	$5.39B	Sell	57,879,303 -465,425	-0.8%	-$44.9M	0.32%	61
2022 Q3	$5.56B	Sell	58,344,728 -339,582	-0.6%	-$33.6M	0.35%	51
2022 Q2	$5.44B	Sell	58,684,310 -576,994	-1%	-$56.3M	0.33%	63
2022 Q1	$6B	Buy	59,261,304 +2,450,990	+4%	+$257M	0.3%	68
2021 Q4	$5.86B	Buy	56,810,314 +1,560,168	+3%	+$144M	0.28%	70
2021 Q3	$4.69B	Buy	55,250,146 +714,932	+1%	+$59.9M	0.25%	81
2021 Q2	$4.55B	Buy	54,535,214 +1,362,699	+3%	+$112M	0.24%	79
2021 Q1	$4B	Sell	53,172,515 -1,288,648	-2%	-$93.9M	0.23%	82
2020 Q4	$3.72B	Sell	54,461,163 -2,030,691	-4%	-$132M	0.23%	84
2020 Q3	$3.3B	Sell	56,491,854 -506,806	-0.9%	-$31.5M	0.23%	89
2020 Q2	$3.7B	Buy	56,998,660 +959,243	+2%	+$60.4M	0.27%	74
2020 Q1	$3.32B	Buy	56,039,417 +251,722	+0.5%	+$16.8M	0.29%	72
2019 Q4	$4.14B	Sell	55,787,695 -4,802,743	-8%	-$337M	0.28%	70
2019 Q3	$3.82B	Sell	60,590,438 -177,488	-0.3%	-$10.5M	0.28%	70
2019 Q2	$3.31B	Sell	60,767,926 -532,899	-0.9%	-$28.7M	0.25%	81
2019 Q1	$3.31B	Buy	61,300,825 +3,100,702	+5%	+$191M	0.26%	78
2018 Q4	$3.81B	Buy	58,200,123 +16,729,536	+40%	+$1.25B	0.35%	55
2018 Q3	$3.26B	Buy	41,470,587 +1,526,225	+4%	+$109M	0.25%	79
2018 Q2	$2.57B	Sell	39,944,362 -1,387,131	-3%	-$91.4M	0.21%	89
2018 Q1	$2.57B	Sell	41,331,493 -1,608,316	-4%	-$115M	0.22%	88
2017 Q4	$3.11B	Buy	42,939,809 +708,067	+2%	+$51.5M	0.25%	82
2017 Q3	$3.43B	Sell	42,231,742 -1,476,035	-3%	-$117M	0.3%	66
2017 Q2	$3.52B	Sell	43,707,777 -354,679	-0.8%	-$28M	0.31%	60
2017 Q1	$3.46B	Sell	44,062,456 -225,591	-0.5%	-$18M	0.31%	63
2016 Q4	$3.49B	Buy	44,288,047 +838,787	+2%	+$67.9M	0.33%	59
2016 Q3	$3.87B	Buy	43,449,260 +530,977	+1%	+$50.1M	0.39%	50
2016 Q2	$4.11B	Sell	42,918,283 -1,633,829	-4%	-$163M	0.44%	48
2016 Q1	$4.62B	Buy	44,552,112 +1,023,799	+2%	+$99.5M	0.5%	39
2015 Q4	$4.26B	Buy	43,528,313 +54,274	+0.1%	+$5.32M	0.47%	44
2015 Q3	$4.19B	Sell	43,474,039 -719,213	-2%	-$75.6M	0.49%	41
2015 Q2	$4.63B	Sell	44,193,252 -2,622,786	-6%	-$268M	0.5%	42
2015 Q1	$4.83B	Sell	46,816,038 -5,005,765	-10%	-$507M	0.5%	39
2014 Q4	$4.99B	Buy	51,821,803 +2,452,688	+5%	+$216M	0.5%	41
2014 Q3	$3.93B	Buy	49,369,115 +1,201,516	+2%	+$94.7M	0.42%	49
2014 Q2	$3.63B	Buy	48,167,599 +647,150	+1%	+$48.9M	0.39%	51
2014 Q1	$3.56B	Sell	47,520,449 -4,707,036	-9%	-$332M	0.4%	49
2013 Q4	$3.74B	Buy	52,227,485 +2,040,943	+4%	+$131M	0.42%	47
2013 Q3	$2.85B	Sell	50,186,542 -2,530,488	-5%	-$151M	0.35%	55
2013 Q2	$3.01B	Buy	+52,717,030	New	+$3.05B	0.39%	50

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street's CVS Position: Q1 2026 in Review

State Street reduced its CVS Health (CVS) stake by 1.4% in Q1 2026, selling an estimated $66.4M and leaving 59,322,181 shares worth $4.26B. The position accounts for 0.15% of the portfolio, ranked #122.

State Street first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $6B in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

State Street held 59,322,181 shares of CVS Health worth $4.26B as of Q1 2026.
State Street sold 861,562 CVS Health shares in Q1 2026, an estimated $66.4M.
CVS Health made up 0.15% of State Street's portfolio in Q1 2026, its #122 holding.
State Street first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
State Street's CVS Health position peaked at $6B in Q1 2022.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.